Melbourne:Â A widely available and affordable blood-thinning drug, heparin, limits lung damage when inhaled by COVID-19 patients, and may also prevent infection from the SARS-CoV-2 virus, according to early results of a study. Researchers from the Australian National University (ANU) and colleagues are tracking hospital patients infected with SARS-CoV-2 in 13 countries who were given doses […]
